Cross Country Healthcare, Inc. (CCRN)

Import this data to Google Sheets with:

=jivedata("CCRN","financials")

Full statements spill as a table. For one cell: =jivedata("CCRN","Revenue") or =jivedata("CCRN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Cross Country Healthcare, Inc.

CCRN • CIK 0001141103

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$2,019,728	$1,344,004	$1,054,293	$1,001,942
Operating Income (Loss)	$112,713	$-16,865	$-84,414	$-87,592
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$102,894	$-16,398	$-83,510	$-86,345
Income Tax Expense (Benefit)	$30,263	$-1,842	$11,342	$12,283
Net Income (Loss) Attributable to Parent	$72,631	$-14,556	$-94,852	$-98,628
Direct Operating Costs	$1,569,318	$1,069,752	$840,722	$799,438
Selling, General and Administrative Expense	$300,391	$233,377	$200,680	$194,006
Accounts Receivable, Credit Loss Expense (Reversal)	$14,562	$21,432	$-441	$-415
Depreciation, Depletion and Amortization	$18,347	$18,200	$16,794	$15,691
Restructuring Charges	$2,553	$4,333	$3,746	$4,210
Asset Impairment Charges	$719	$2,888	$77,851	$78,084
Costs and Expenses	$1,907,015	$1,360,869	$1,138,707	$1,089,534
InterestExpenseNonoperating	—	$2,188	$2,216	$2,240
Gain (Loss) on Extinguishment of Debt	$-1,723	$0	$0	$0
Investment Income, Interest	—	$2,050	$3,129	$3,422
Other Nonoperating Income (Expense)	$-2	$605	$-9	$65
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	$2	$-56	$-119	$-253
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$72,633	$-14,612	$-94,971	$-98,881
Weighted Average Number of Shares Outstanding, Basic	35,158,000	33,379,000	32,409,000	31,597,000
Weighted Average Number of Shares Outstanding, Diluted	35,476,000	33,379,000	32,409,000	31,597,000
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	318,000	0	0	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$17,094	$81,633	$108,738	$105,584
Accounts Receivable, after Allowance for Credit Loss, Current	$372,352	$223,238	$167,512	$176,641
Property, Plant and Equipment, Net	$27,339	$28,850	$27,775	$27,313
Income Taxes Receivable, Current	$6,898	$10,389	$3,594	$3,065
Operating Lease, Right-of-Use Asset	$2,599	$2,468	$2,206	$1,780
Prepaid Expense, Current	$7,681	$7,848	$7,561	$7,412
Goodwill	$135,430	$135,060	$63,803	$63,803
Insurance Settlements Receivable, Current	$9,097	$9,255	$4,851	$4,340
Intangible Assets, Net (Excluding Goodwill)	$54,468	$42,186	$27,635	$25,764
Other Assets, Current	$2,031	$2,637	$1,333	$1,257
Deferred Income Tax Assets, Net	$5,954	$8,104	$0	$0
Assets, Current	$415,153	$335,000	$293,589	$298,299
Insurance Settlements Receivable, Noncurrent	$25,714	$20,928	$14,859	$14,334
Deferred Compensation Plan Assets	$3,298	$2,889	$2,938	$2,868
Other Assets, Noncurrent	$6,673	$5,809	$2,118	$1,762
Assets	$679,317	$589,251	$448,951	$451,073
Operating Lease, Liability, Noncurrent	$2,663	$1,782	$1,155	$1,069
Deferred Income Tax Liabilities, Net	—	—	$2,522	$2,696
Liability for Claims and Claims Adjustment Expense	$34,853	$34,425	$30,028	$30,012
Liability for Uncertainty in Income Taxes, Noncurrent	$10,603	$10,117	$10,427	$10,508
Deferred Compensation Liability, Classified, Noncurrent	$3,343	$2,926	$2,590	$2,244
Other Liabilities, Noncurrent	$4,218	$3,566	$1,651	$1,170
Liabilities	$205,924	$170,292	$126,129	$138,266
Accounts Payable and Other Accrued Liabilities, Current	$85,333	$64,946	$46,034	$47,596
Employee-related Liabilities, Current	$52,297	$47,646	$28,378	$39,524
Operating Lease, Liability, Current	$2,604	$2,089	$1,163	$974
Business Combination, Contingent Consideration, Liability, Current	$6,794	$4,411	$0	$0
Other Liabilities, Current	$1,559	$1,310	$2,181	$2,473
Liabilities, Current	$148,587	$120,402	$77,756	$90,567
Common Stock, Value, Issued	$4	$3	$3	$3
Additional Paid in Capital, Common Stock	$236,417	$202,338	$201,172	$195,552
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-1,385	$-1,441	$-1,560	$-1,689
Retained Earnings (Accumulated Deficit)	$238,357	$218,059	$123,207	$118,941
Stockholders' Equity Attributable to Parent	$473,393	$418,959	$322,822	$312,807
Accounts Receivable, Allowance for Credit Loss, Current	$20,547	$9,301	$9,112	$8,727
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	34,384,905	32,277,395	31,721,280	31,721,280
Insurance Receivable for Malpractice, Current	$5,524	$5,279	$1,831	$1,831
Insurance Receivable for Malpractice, Noncurrent	$17,677	$12,767	$6,261	$6,261
Deposits Assets, Noncurrent	$720	$1,063	$1,006	$1,006
Debt Issuance Costs, Noncurrent, Net	$2,623	$1,807	$993	$993
Accounts Payable, Trade, Current	$3,040	$5,744	$2,044	$2,044
Accrued Liabilities, Current	$15,946	$21,412	$24,646	$24,646
Accrued Salaries, Current	$27,042	$24,606	$13,241	$13,241
Accrued Bonuses, Current	$2,893	$2,615	$1,589	$1,589
Workers' Compensation Liability, Current	$8,476	$8,383	$7,054	$7,054
Malpractice Loss Contingency, Accrual, Undiscounted, Current	$6,252	$6,121	$2,440	$2,440
Other Employee-related Liabilities, Current	$6,550	$4,768	$2,979	$2,979
Accrued Vacation, Current	$1,084	$1,153	$1,075	$1,075
Workers' Compensation Liability, Noncurrent	$14,798	$15,355	$15,772	$15,772
Malpractice Loss Contingency, Accrual, Undiscounted, Noncurrent	$20,055	$19,070	$14,256	$14,256
Restructuring Reserve, Noncurrent	$474	$74	$0	$0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$72,631	$-14,556	$-94,852	$-98,628
Net Cash Provided by (Used in) Operating Activities	$248,498	$120,116	$48,251	$47,337
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$8	$-14	$21	$20
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$13,490	$64,539	$27,105	$24,887
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$17,094	$81,633	$108,738	$133,625
Depreciation, Depletion and Amortization	$18,347	$18,200	$16,794	$15,691
Payments to Acquire Property, Plant, and Equipment	$13,974	$8,714	$8,161	$7,733
Deferred Income Tax Expense (Benefit)	$1,304	$-1,944	$10,068	$10,967
Net Cash Provided by (Used in) Investing Activities	$-13,775	$-8,714	$-8,161	$-7,733
Asset Impairment Charges	$719	$2,888	$77,851	$78,084
Gain (Loss) on Extinguishment of Debt	$-1,723	$0	$0	$0
Share-based Payment Arrangement, Noncash Expense	$6,579	$6,025	$7,144	$6,997
Other Noncash Income (Expense)	$-1,252	$-99	$-755	$-753
Repayments of Secured Debt	$73,875	$0	$0	$0
Proceeds from Long-term Lines of Credit	$720,991	$18,024	$1,449	$1,448
Repayments of Long-term Lines of Credit	$797,791	$18,024	$1,449	$1,448
Payment, Tax Withholding, Share-based Payment Arrangement	$4,904	$2,960	$1,762	$2,350
Payment for Contingent Consideration Liability, Financing Activities	$7,500	$6,579	$4,411	$0
Payments for Repurchase of Common Stock	$57,654	$37,310	$6,833	$12,387
Proceeds from (Payments for) Other Financing Activities	$-508	$0	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-221,241	$-46,849	$-13,006	$-14,737
Interest Paid, Excluding Capitalized Interest, Operating Activities	$7,534	$1,373	$1,397	$1,397
Income Taxes Paid, Net	—	—	$-5,687	$-5,687
Increase (Decrease) in Accounts Receivable	$-251,427	$-128,327	$-56,726	$-44,103
Increase (Decrease) in Other Operating Assets	$-268	$4,990	$2,334	$2,129
Increase (Decrease) in Income Taxes Payable	$6,955	$-2,278	$7,176	$3,177
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-126,611	$-29,753	$-34,570	$-11,762
Increase (Decrease) in Other Operating Liabilities	$-191	$-890	$5,656	$1,959

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CCRN","financials")

Full statements spill as a table. For one cell: =jivedata("CCRN","Revenue") or =jivedata("CCRN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.